[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fXB18EdsFRg8iiw0P2tNEV6gnHL4R9bBdSjvaBR0-8d0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":40,"rows":47},"Copenhagen University Hospital at Herlev",[4],76,false,9,7,99356,1,53,[14,17,19,22,25,27,29,32],{"name":15,"count":16},"Atherosclerosis",5,{"name":18,"count":16},"Intermittent Claudication",{"name":20,"count":21},"Urinary Incontinence",4,{"name":23,"count":24},"Prostatic Neoplasms",3,{"name":26,"count":24},"Breast Cancer",{"name":28,"count":24},"Malnutrition",{"name":30,"count":31},"Prostate Cancer",2,{"name":33,"count":31},"MRI",[35],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05957991","Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty","2026-08-30","Metformin Hydrochloride",[41,42,43,44,45,46],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[48,72,98,129,147,172,201,219,237,255,281,309,327,345,373,400,418,444,462,489,507,545,570,597,615,633,660,684,707,732,759,790,814],{"intervention":39,"totalTrials":11,"cells":49},{"EARLY_PHASE1":50,"PHASE1":53,"PHASE2":55,"PHASE3":57,"PHASE4":59,"NA":61},{"trials":51,"activeCount":52},[],0,{"trials":54,"activeCount":52},[],{"trials":56,"activeCount":52},[],{"trials":58,"activeCount":52},[],{"trials":60,"activeCount":52},[],{"trials":62,"activeCount":11,"soonestReadout":38},[63],{"nctId":36,"briefTitle":37,"status":64,"phases":65,"primaryCompletion":38,"completion":66,"start":67,"enrollment":68,"conditions":69,"interventions":71},"NOT_YET_RECRUITING",[],"2030-09","2023-09-01",1500,[70],"Puberty, Precocious",[39],{"intervention":73,"totalTrials":11,"cells":74},"rhTSH",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":96},{"trials":76,"activeCount":52},[],{"trials":78,"activeCount":52},[],{"trials":80,"activeCount":52},[],{"trials":82,"activeCount":52},[],{"trials":84,"activeCount":52},[85],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":95},"NCT00604318","Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer","COMPLETED",[45],"2012-02","2008-02",56,[94],"Thyroid Cancer",[73],{"trials":97,"activeCount":52},[],{"intervention":99,"totalTrials":11,"cells":100},"Propofol sedation",{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":127},{"trials":102,"activeCount":52},[],{"trials":104,"activeCount":52},[],{"trials":106,"activeCount":52},[],{"trials":108,"activeCount":52},[],{"trials":110,"activeCount":52},[111],{"nctId":112,"briefTitle":113,"status":114,"phases":115,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":120,"interventions":125},"NCT02226328","Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.","UNKNOWN",[45],"2015-12","2016-04","2014-11",128,[121,122,123,124],"Flexible Bronchoscopy","Sedation","Satisfaction","Safety",[99,126],"Midazolam and Fentanyl sedation",{"trials":128,"activeCount":52},[],{"intervention":126,"totalTrials":11,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":145},{"trials":132,"activeCount":52},[],{"trials":134,"activeCount":52},[],{"trials":136,"activeCount":52},[],{"trials":138,"activeCount":52},[],{"trials":140,"activeCount":52},[141],{"nctId":112,"briefTitle":113,"status":114,"phases":142,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":143,"interventions":144},[45],[121,122,123,124],[99,126],{"trials":146,"activeCount":52},[],{"intervention":148,"totalTrials":11,"cells":149},"Infliximab",{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":158,"NA":170},{"trials":151,"activeCount":52},[],{"trials":153,"activeCount":52},[],{"trials":155,"activeCount":52},[],{"trials":157,"activeCount":52},[],{"trials":159,"activeCount":52},[160],{"nctId":161,"briefTitle":162,"status":88,"phases":163,"primaryCompletion":164,"completion":164,"start":165,"enrollment":166,"conditions":167,"interventions":169},"NCT01817426","Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission",[45],"2020-05","2013-01",115,[168],"Crohn Disease",[148],{"trials":171,"activeCount":52},[],{"intervention":173,"totalTrials":11,"cells":174},"Estradiol",{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":199},{"trials":176,"activeCount":52},[],{"trials":178,"activeCount":52},[],{"trials":180,"activeCount":52},[],{"trials":182,"activeCount":52},[],{"trials":184,"activeCount":52},[185],{"nctId":186,"briefTitle":187,"status":88,"phases":188,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":193,"interventions":195},"NCT04997525","Estradiol and Progesterone Levels Following Frozen Embryo Transfer",[45],"2024-05-07","2024-12-06","2021-04-20",305,[194],"Infertility",[173,196,197,198],"Progesterone","Follitropin Alfa","Chorionic Gonadotropin, Alpha",{"trials":200,"activeCount":52},[],{"intervention":196,"totalTrials":11,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":217},{"trials":204,"activeCount":52},[],{"trials":206,"activeCount":52},[],{"trials":208,"activeCount":52},[],{"trials":210,"activeCount":52},[],{"trials":212,"activeCount":52},[213],{"nctId":186,"briefTitle":187,"status":88,"phases":214,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":215,"interventions":216},[45],[194],[173,196,197,198],{"trials":218,"activeCount":52},[],{"intervention":197,"totalTrials":11,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":235},{"trials":222,"activeCount":52},[],{"trials":224,"activeCount":52},[],{"trials":226,"activeCount":52},[],{"trials":228,"activeCount":52},[],{"trials":230,"activeCount":52},[231],{"nctId":186,"briefTitle":187,"status":88,"phases":232,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":233,"interventions":234},[45],[194],[173,196,197,198],{"trials":236,"activeCount":52},[],{"intervention":198,"totalTrials":11,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":247,"NA":253},{"trials":240,"activeCount":52},[],{"trials":242,"activeCount":52},[],{"trials":244,"activeCount":52},[],{"trials":246,"activeCount":52},[],{"trials":248,"activeCount":52},[249],{"nctId":186,"briefTitle":187,"status":88,"phases":250,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":251,"interventions":252},[45],[194],[173,196,197,198],{"trials":254,"activeCount":52},[],{"intervention":256,"totalTrials":11,"cells":257},"Triiodothyronine",{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":264,"PHASE4":266,"NA":279},{"trials":259,"activeCount":52},[],{"trials":261,"activeCount":52},[],{"trials":263,"activeCount":52},[],{"trials":265,"activeCount":52},[],{"trials":267,"activeCount":52},[268],{"nctId":269,"briefTitle":270,"status":88,"phases":271,"completion":272,"start":273,"enrollment":274,"conditions":275,"interventions":278},"NCT00531713","Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism",[45],"2007-03","2003-04",59,[276,277],"Quality of Life","Depression",[256],{"trials":280,"activeCount":52},[],{"intervention":282,"totalTrials":11,"cells":283},"Propofol",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":307},{"trials":285,"activeCount":52},[],{"trials":287,"activeCount":52},[],{"trials":289,"activeCount":52},[],{"trials":291,"activeCount":52},[],{"trials":293,"activeCount":52},[294],{"nctId":295,"briefTitle":296,"status":88,"phases":297,"primaryCompletion":298,"completion":298,"start":299,"enrollment":300,"conditions":301,"interventions":304},"NCT01934088","Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy",[45],"2015-09","2014-01",130,[302,303,122],"Inflammatory Bowel Disease","Endoscopy",[282,305,306],"Midazolam","Fentanyl",{"trials":308,"activeCount":52},[],{"intervention":305,"totalTrials":11,"cells":310},{"EARLY_PHASE1":311,"PHASE1":313,"PHASE2":315,"PHASE3":317,"PHASE4":319,"NA":325},{"trials":312,"activeCount":52},[],{"trials":314,"activeCount":52},[],{"trials":316,"activeCount":52},[],{"trials":318,"activeCount":52},[],{"trials":320,"activeCount":52},[321],{"nctId":295,"briefTitle":296,"status":88,"phases":322,"primaryCompletion":298,"completion":298,"start":299,"enrollment":300,"conditions":323,"interventions":324},[45],[302,303,122],[282,305,306],{"trials":326,"activeCount":52},[],{"intervention":306,"totalTrials":11,"cells":328},{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":343},{"trials":330,"activeCount":52},[],{"trials":332,"activeCount":52},[],{"trials":334,"activeCount":52},[],{"trials":336,"activeCount":52},[],{"trials":338,"activeCount":52},[339],{"nctId":295,"briefTitle":296,"status":88,"phases":340,"primaryCompletion":298,"completion":298,"start":299,"enrollment":300,"conditions":341,"interventions":342},[45],[302,303,122],[282,305,306],{"trials":344,"activeCount":52},[],{"intervention":346,"totalTrials":11,"cells":347},"SmofKabiven",{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":356,"NA":371},{"trials":349,"activeCount":52},[],{"trials":351,"activeCount":52},[],{"trials":353,"activeCount":52},[],{"trials":355,"activeCount":52},[],{"trials":357,"activeCount":52},[358],{"nctId":359,"briefTitle":360,"status":114,"phases":361,"primaryCompletion":362,"completion":363,"start":364,"enrollment":365,"conditions":366,"interventions":370},"NCT06089551","Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery",[45],"2025-10-25","2026-01-01","2023-10-18",342,[367,368,369],"Laparotomy","Bowel Obstruction","Ischemia, Mesenteric",[346],{"trials":372,"activeCount":52},[],{"intervention":374,"totalTrials":11,"cells":375},"Dexamethasone",{"EARLY_PHASE1":376,"PHASE1":378,"PHASE2":380,"PHASE3":382,"PHASE4":396,"NA":398},{"trials":377,"activeCount":52},[],{"trials":379,"activeCount":52},[],{"trials":381,"activeCount":52},[],{"trials":383,"activeCount":52},[384],{"nctId":385,"briefTitle":386,"status":88,"phases":387,"primaryCompletion":388,"completion":389,"start":390,"enrollment":391,"conditions":392,"interventions":394},"NCT00909077","The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)",[44],"2012-06-01","2017-08-01","2004-08",155,[393],"Idiopathic Thrombocytopenic Purpura",[374,395],"Dexamethasone and Rituximab",{"trials":397,"activeCount":52},[],{"trials":399,"activeCount":52},[],{"intervention":395,"totalTrials":11,"cells":401},{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":414,"NA":416},{"trials":403,"activeCount":52},[],{"trials":405,"activeCount":52},[],{"trials":407,"activeCount":52},[],{"trials":409,"activeCount":52},[410],{"nctId":385,"briefTitle":386,"status":88,"phases":411,"primaryCompletion":388,"completion":389,"start":390,"enrollment":391,"conditions":412,"interventions":413},[44],[393],[374,395],{"trials":415,"activeCount":52},[],{"trials":417,"activeCount":52},[],{"intervention":419,"totalTrials":11,"cells":420},"prednisolone + mabthera",{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":425,"PHASE3":427,"PHASE4":440,"NA":442},{"trials":422,"activeCount":52},[],{"trials":424,"activeCount":52},[],{"trials":426,"activeCount":52},[],{"trials":428,"activeCount":52},[429],{"nctId":430,"briefTitle":431,"status":88,"phases":432,"primaryCompletion":433,"completion":433,"start":434,"enrollment":435,"conditions":436,"interventions":438},"NCT01134432","Prednisolone +\u002F- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia",[44],"2012-07","2005-03",65,[437],"Anemia, Hemolytic, Autoimmune",[419,439],"Prednisolone",{"trials":441,"activeCount":52},[],{"trials":443,"activeCount":52},[],{"intervention":439,"totalTrials":11,"cells":445},{"EARLY_PHASE1":446,"PHASE1":448,"PHASE2":450,"PHASE3":452,"PHASE4":458,"NA":460},{"trials":447,"activeCount":52},[],{"trials":449,"activeCount":52},[],{"trials":451,"activeCount":52},[],{"trials":453,"activeCount":52},[454],{"nctId":430,"briefTitle":431,"status":88,"phases":455,"primaryCompletion":433,"completion":433,"start":434,"enrollment":435,"conditions":456,"interventions":457},[44],[437],[419,439],{"trials":459,"activeCount":52},[],{"trials":461,"activeCount":52},[],{"intervention":463,"totalTrials":11,"cells":464},"Fibrinogen Concentrate",{"EARLY_PHASE1":465,"PHASE1":467,"PHASE2":469,"PHASE3":471,"PHASE4":485,"NA":487},{"trials":466,"activeCount":52},[],{"trials":468,"activeCount":52},[],{"trials":470,"activeCount":52},[],{"trials":472,"activeCount":52},[473],{"nctId":474,"briefTitle":475,"status":88,"phases":476,"primaryCompletion":477,"completion":478,"start":479,"enrollment":480,"conditions":481,"interventions":483},"NCT01359878","Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial",[43,44],"2013-05","2013-07","2011-05",249,[482],"Postpartum Haemorrhage",[463,484],"Isotonic Saline",{"trials":486,"activeCount":52},[],{"trials":488,"activeCount":52},[],{"intervention":484,"totalTrials":11,"cells":490},{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":503,"NA":505},{"trials":492,"activeCount":52},[],{"trials":494,"activeCount":52},[],{"trials":496,"activeCount":52},[],{"trials":498,"activeCount":52},[499],{"nctId":474,"briefTitle":475,"status":88,"phases":500,"primaryCompletion":477,"completion":478,"start":479,"enrollment":480,"conditions":501,"interventions":502},[43,44],[482],[463,484],{"trials":504,"activeCount":52},[],{"trials":506,"activeCount":52},[],{"intervention":508,"totalTrials":31,"cells":509},"Bleomycin",{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":524,"PHASE3":539,"PHASE4":541,"NA":543},{"trials":511,"activeCount":52},[],{"trials":513,"activeCount":52},[514],{"nctId":515,"briefTitle":516,"status":517,"phases":518,"primaryCompletion":478,"completion":478,"start":519,"enrollment":11,"conditions":520,"interventions":523},"NCT01322100","Electrochemotherapy as a Palliative Treatment for Brain Metastases","TERMINATED",[42],"2011-04",[521,522],"Brain Metastases","CNS Metastases",[508],{"trials":525,"activeCount":52},[526],{"nctId":527,"briefTitle":528,"status":529,"phases":530,"primaryCompletion":531,"completion":532,"start":533,"enrollment":534,"conditions":535,"interventions":537},"NCT00918593","Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy","WITHDRAWN",[43],"2013-08","2014-02","2009-12",98,[536],"Ulcerated Cutaneous Metastases",[538,508],"Electrochemotherapy",{"trials":540,"activeCount":52},[],{"trials":542,"activeCount":52},[],{"trials":544,"activeCount":52},[],{"intervention":546,"totalTrials":11,"cells":547},"Ascorbic Acid",{"EARLY_PHASE1":548,"PHASE1":550,"PHASE2":552,"PHASE3":564,"PHASE4":566,"NA":568},{"trials":549,"activeCount":52},[],{"trials":551,"activeCount":52},[],{"trials":553,"activeCount":52},[554],{"nctId":555,"briefTitle":556,"status":88,"phases":557,"primaryCompletion":558,"completion":559,"start":560,"enrollment":561,"conditions":562,"interventions":563},"NCT01080352","Vitamin C as an Anti-cancer Drug",[43],"2014-09","2015-03","2010-11",31,[23],[546],{"trials":565,"activeCount":52},[],{"trials":567,"activeCount":52},[],{"trials":569,"activeCount":52},[],{"intervention":571,"totalTrials":11,"cells":572},"Oxaliplatin",{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":591,"PHASE4":593,"NA":595},{"trials":574,"activeCount":52},[],{"trials":576,"activeCount":52},[],{"trials":578,"activeCount":52},[579],{"nctId":580,"briefTitle":581,"status":114,"phases":582,"primaryCompletion":583,"completion":584,"start":585,"enrollment":586,"conditions":587,"interventions":589},"NCT01511146","Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor",[43],"2015-07","2016-07","2011-07",100,[588],"Liver Metastasis",[571,590],"Mitomycin + Gemcitabine",{"trials":592,"activeCount":52},[],{"trials":594,"activeCount":52},[],{"trials":596,"activeCount":52},[],{"intervention":590,"totalTrials":11,"cells":598},{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":609,"PHASE4":611,"NA":613},{"trials":600,"activeCount":52},[],{"trials":602,"activeCount":52},[],{"trials":604,"activeCount":52},[605],{"nctId":580,"briefTitle":581,"status":114,"phases":606,"primaryCompletion":583,"completion":584,"start":585,"enrollment":586,"conditions":607,"interventions":608},[43],[588],[571,590],{"trials":610,"activeCount":52},[],{"trials":612,"activeCount":52},[],{"trials":614,"activeCount":52},[],{"intervention":538,"totalTrials":11,"cells":616},{"EARLY_PHASE1":617,"PHASE1":619,"PHASE2":621,"PHASE3":627,"PHASE4":629,"NA":631},{"trials":618,"activeCount":52},[],{"trials":620,"activeCount":52},[],{"trials":622,"activeCount":52},[623],{"nctId":527,"briefTitle":528,"status":529,"phases":624,"primaryCompletion":531,"completion":532,"start":533,"enrollment":534,"conditions":625,"interventions":626},[43],[536],[538,508],{"trials":628,"activeCount":52},[],{"trials":630,"activeCount":52},[],{"trials":632,"activeCount":52},[],{"intervention":634,"totalTrials":11,"cells":635},"HDAC inhibitor",{"EARLY_PHASE1":636,"PHASE1":638,"PHASE2":640,"PHASE3":654,"PHASE4":656,"NA":658},{"trials":637,"activeCount":52},[],{"trials":639,"activeCount":52},[],{"trials":641,"activeCount":52},[642],{"nctId":643,"briefTitle":644,"status":114,"phases":645,"primaryCompletion":646,"completion":647,"start":648,"enrollment":649,"conditions":650,"interventions":653},"NCT00866762","A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia",[43],"2012-08","2012-12","2009-02",60,[651,652],"Polycythemia Vera","Essential Thrombocythemia",[634],{"trials":655,"activeCount":52},[],{"trials":657,"activeCount":52},[],{"trials":659,"activeCount":52},[],{"intervention":661,"totalTrials":11,"cells":662},"cetuximab",{"EARLY_PHASE1":663,"PHASE1":665,"PHASE2":667,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":664,"activeCount":52},[],{"trials":666,"activeCount":52},[],{"trials":668,"activeCount":52},[669],{"nctId":670,"briefTitle":671,"status":114,"phases":672,"primaryCompletion":433,"completion":673,"start":674,"enrollment":649,"conditions":675,"interventions":677},"NCT00964457","Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients",[43],"2017-07","2009-08",[676],"Rectum Cancer",[661],{"trials":679,"activeCount":52},[],{"trials":681,"activeCount":52},[],{"trials":683,"activeCount":52},[],{"intervention":685,"totalTrials":11,"cells":686},"Plasmid AMEP",{"EARLY_PHASE1":687,"PHASE1":689,"PHASE2":699,"PHASE3":701,"PHASE4":703,"NA":705},{"trials":688,"activeCount":52},[],{"trials":690,"activeCount":52},[691],{"nctId":692,"briefTitle":693,"status":517,"phases":694,"primaryCompletion":695,"completion":695,"start":433,"enrollment":9,"conditions":696,"interventions":698},"NCT01664273","Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer",[42],"2015-05",[697],"Metastatic Malignant Neoplasm",[685],{"trials":700,"activeCount":52},[],{"trials":702,"activeCount":52},[],{"trials":704,"activeCount":52},[],{"trials":706,"activeCount":52},[],{"intervention":708,"totalTrials":11,"cells":709},"Whole exome sequencing",{"EARLY_PHASE1":710,"PHASE1":712,"PHASE2":714,"PHASE3":716,"PHASE4":718,"NA":720},{"trials":711,"activeCount":52},[],{"trials":713,"activeCount":52},[],{"trials":715,"activeCount":52},[],{"trials":717,"activeCount":52},[],{"trials":719,"activeCount":52},[],{"trials":721,"activeCount":52},[722],{"nctId":723,"briefTitle":724,"status":88,"phases":725,"primaryCompletion":726,"completion":726,"start":727,"enrollment":728,"conditions":729,"interventions":731},"NCT05736237","Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen Development",[],"2024-05-31","2023-05-01",20,[730],"Optic Disk Drusen",[708],{"intervention":733,"totalTrials":11,"cells":734},"Skin Care Program",{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":741,"PHASE4":743,"NA":745},{"trials":736,"activeCount":52},[],{"trials":738,"activeCount":52},[],{"trials":740,"activeCount":52},[],{"trials":742,"activeCount":52},[],{"trials":744,"activeCount":52},[],{"trials":746,"activeCount":52},[747],{"nctId":748,"briefTitle":749,"status":88,"phases":750,"primaryCompletion":751,"completion":752,"start":753,"enrollment":754,"conditions":755,"interventions":758},"NCT04258904","Prevention of Skin Problems With Diabetes Devices in Pediatric Patients",[46],"2022-09-20","2022-11-30","2020-03-10",236,[756,757],"Type 1 Diabetes","Dermatologic Complication",[733],{"intervention":760,"totalTrials":11,"cells":761},"Bismuth",{"EARLY_PHASE1":762,"PHASE1":764,"PHASE2":766,"PHASE3":768,"PHASE4":770,"NA":772},{"trials":763,"activeCount":52},[],{"trials":765,"activeCount":52},[],{"trials":767,"activeCount":52},[],{"trials":769,"activeCount":52},[],{"trials":771,"activeCount":52},[],{"trials":773,"activeCount":52},[774],{"nctId":775,"briefTitle":776,"status":88,"phases":777,"primaryCompletion":778,"completion":779,"start":780,"enrollment":781,"conditions":782,"interventions":789},"NCT00892502","Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?",[46],"2012-01","2013-02","2009-05",50,[783,784,785,786,787,788],"Hematological Diseases","Hematological Malignancies","Blood Diseases","Malignant Lymphoma","Leukemia","Multiple Myeloma",[760],{"intervention":791,"totalTrials":11,"cells":792},"methylprednisoloneacetate",{"EARLY_PHASE1":793,"PHASE1":795,"PHASE2":797,"PHASE3":799,"PHASE4":801,"NA":803},{"trials":794,"activeCount":52},[],{"trials":796,"activeCount":52},[],{"trials":798,"activeCount":52},[],{"trials":800,"activeCount":52},[],{"trials":802,"activeCount":52},[],{"trials":804,"activeCount":52},[805],{"nctId":806,"briefTitle":807,"status":114,"phases":808,"primaryCompletion":809,"completion":646,"start":810,"enrollment":811,"conditions":812,"interventions":813},"NCT01380912","Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer",[],"2011-08","2010-08",160,[26],[791],{"intervention":815,"totalTrials":11,"cells":816},"Solu-Medrol",{"EARLY_PHASE1":817,"PHASE1":819,"PHASE2":821,"PHASE3":823,"PHASE4":825,"NA":827},{"trials":818,"activeCount":52},[],{"trials":820,"activeCount":52},[],{"trials":822,"activeCount":52},[],{"trials":824,"activeCount":52},[],{"trials":826,"activeCount":52},[],{"trials":828,"activeCount":52},[829],{"nctId":830,"briefTitle":831,"status":114,"phases":832,"primaryCompletion":833,"completion":834,"start":835,"enrollment":781,"conditions":836,"interventions":839},"NCT03942861","Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.",[],"2021-09-21","2022-02-21","2019-02-21",[837,838],"Ulcerative Colitis","Ultrasound Therapy; Complications",[815]]